Deals and M&As this week: Clutch, Sam McCauley Chemist

Clutch has secured $2.3m in a seed funding round co-led by Carolina Angel Network and Duke Angel Network.

The round also saw the participation of LaunchCapital, Rubicon Venture Capital and Triangle Angel Partners.

The funding will enable Clutch to offer life-changing products to a larger audience.

Sam McCauley Chemist has completed an acquisition of Life Pharmacy and Fermoy Medical Hall for €5m ($6.8m).

Sam McCauley is an operator of health and beauty stores.

All three of the companies are based in Ireland.

Life Pharmacy is located in Dublin, while Fermoy Medical Hall is based in Cork. The two pharmacies generate combined revenue of more than €5.5m ($6.8m).

Cure Fit Healthcare has raised Rs41.8m ($0.64m) from Binny Bansal and Ananth Narayanan through a venture funding round.

Based in India, Cure Fit Healthcare is a health management platform featuring services such as eat.fit, cult.fit and mind.fit.

Cure Fit Healthcare was co-founded by Mukesh Bansal and Ankit Nagori.

Alcheme Skincare has raised funds through a seed funding round led by DSG Consumer Partners.

The funding round also witnessed participation from Kenneth Bishop.

Based in Singapore, Alcheme Skincare provides personalised skincare solutions.

The funding is intended to be used for the development of new products, expansion to south-east Asia, and the establishment of a research and development (R&D) and production laboratory.

Perfect Corporation and Amway have launched a new app named Artistry Virtual Beauty.

The app allows users to try Amway’s make-up stock-keeping units (SKU) virtually and offer personalised skincare solutions based on their skin problems.

It integrates Perfect Corporation’s artificial intelligence (AI) technology and Artistry’s skin assessment tool.

The company will initially launch the app in South Korea and later expand to Japan, Thailand and the US. It can be downloaded from the Apple App Store and Google Play.

Pacific Glory Development has completed an acquisition of the remaining 60% interest in Unigreg from Alliance Pharmaceuticals for £2.9m ($4.14m).

After the transaction, Unigreg will become a wholly-owned subsidiary of Pacific Glory Development.

The purchase consideration is being paid partly in cash and partly in deferred payment on or before 16 April 2019.

Based in the UK, Alliance Pharmaceuticals is a subsidiary of Alliance Pharma, while Unigreg is a producer of pharmaceutical products.

Numis Securities and Investec Bank are the financial advisors to Alliance Pharmaceuticals for the transaction.

Integumen has entered an agreement to acquire Cellulac for an undisclosed sum.

The consideration for the transaction includes 84% in shares and the remaining in cash.

Based in Ireland, Integumen is a personal healthcare firm, while Cellulac is an industrial biochemicals investment technology firm based in the UK.

Integumen also intends to raise £7.5m ($10.67m) through an equity placement or debt funding.

The combined firm aims to replace the existing Integumen’s cosmetic packaging with biodegradable plastic materials.

SPARK Advisory Partners is the nominated adviser for the deal, while Hybridan LLP and Turner Pope Investments (TPI) are the brokers.

Comvita is looking for potential buyers.

Founded in 1974, Comvita is a New Zealand-based producer of natural health and skincare products.

Scott Coulter is serving as CEO of the firm.